ADELAIDA ALFONSO: Open Payments
NPI 1275121790 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 29 payments from 7 companies in 2025. Trend: 2023 $499 · 2024 $751 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $227 |
| ABBVIE INC. | 6 | $145 |
| Phathom Pharmaceuticals, Inc. | 9 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Ardelyx, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $17 |
Products named: REZDIFFRA, VOQUEZNA, ENTYVIO, RINVOQ, XIFAXAN, CREON, EOHILIA, MAVYRET.
Industry payments across FL — which companies pay providers there.
